At VerGo Pharma Research, our R&D Division provides comprehensive end-to-end pharmaceutical product development services, specializing in generic formulations. As a trusted Pharma Product Development CRO, we support global clients in developing robust, regulatory-compliant products for submission to major health authorities.
As a specialized provider of Pharma Powder for Suspension (PFOS) development and manufacturing services, VerGo Pharma Research has the technical and regulatory capability to support challenging suspension formulations. Additionally, pharma liquid products development services cover both aqueous and non-aqueous solutions, suspensions, emulsions, and reconstitutable liquids. We develop and manufacture oral and ophthalmic liquids.
We have expertise in various technologies for development of conventional to complex delivery systems. Our success is attributed to application of Quality by Design concept throughout development process for delivery of robust products. We have capability to develop high potent molecules in our special product area which is designed to handle the potent molecules. We have successfully developed more than 50 products which includes NCE -1 products, complex generics and innovative combination products for clinical studies. Our product development team includes 50+ qualified scientists with diverse experience in different technologies and scientific expertise.
State of the art Analytical R&D facility to meet the ever-rising demands of the global healthcare industry. Experience scientists and advanced capabilities lead to fast and scientifically sound results. We support the development of drug substances, impurities, by-products & drug products and are focused on accelerating the product development cycle.
VerGo’s R&D is integrated with inhouse Development Quality Assurance team which ensures compliance to all quality procedure during routine Research & Development activities.